You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 2, August 1951 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Notes
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

FIXED DRUG ERUPTION AND EPIDIDYMITIS DUE TO ANTIPYRINE

HUGH McCULLOCH, M.D.; I. ZELIGMAN, M.D., D.Med.Sci.

AMA Arch Derm Syphilol. 1951;64(2):198-199.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Brocq1 in 1894 introduced the term "fixed drug eruption" to denote an unusual form of eruption produced by the ingestion of antipyrine. The chief characteristic of this eruption was that it recurred in the primarily affected area each time antipyrine was taken. The manifestations were erythematous, pigmentary or vesiculobullous plaques sometimes involving the mucosal orifices. The term "fixed"2 has since been extended to various types of eruptions, such as urticarial, erythematous or eczematous ones, that reappear in the parent site as a result of the use of a drug. J. Jadassohn3 extended the term "fixed" to include extracutaneous effects from drugs characterized by the recurrence of symptoms in the original sites in tissues other than the skin or mucous membranes. The case reported below is an example of a typical fixed drug eruption and an unusual extracutaneous effect, an epididymitis, due to the ingestion of antipyrine.

REPORT OF A CASE . . . [Full Text PDF of this Article]


Author Affiliations

BALTIMORE


Footnotes

Sponsored by the Veterans Administration and published with the approval of the Chief Medical Director. The statements and conclusions published by the authors are the result of their own study and do not necessarily reflect the opinion or policy of the Veterans Administration.

Resident in Training in Dermatology and Syphilology, Veterans Administration Hospital, Fort Howard, Md. (Dr. McCulloch), and Attending Physician in Dermatology and Syphilology, Veterans Administration Hospital, Fort Howard, Md.; Instructor in Dermatology, Johns Hopkins University School of Medicine, and Assistant Dermatologist, Johns Hopkins Hospital (Dr. Zeligman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1951 American Medical Association. All Rights Reserved.